Search

Welcome to All The Buzz DC! Our store is open everyday from 10AM – 9PM. With your purchase of an All the Buzz t-shirt, you can select a free gift of 3.5 grams of flower. Make sure to visit our Beehive ASAP so that you don’t miss out on some of the best flower in Washington DC! We are knowledgeable on flower strains and can assist in helping you chose the flower that gives you that special feeling you are looking for. All The Buzz DC WEBSITE MENU REVIEWS 3232 Georgia Ave NW, Washington, DC (202) 803-2263 Welcome to All The Buzz DC! Our store is open everyday from 10AM – 9PM. With your purchase of an All the Buzz t-shirt, you can select a free gift of 3.5 grams of flower. Make sure to visit our Beehive ASAP so that you don’t miss out on some of the best flower in Washington DC! We are knowledgeable on flower strains and can assist in helping you chose the flower that gives you that special feeling you are looking for. All The Buzz DC is I-71 complaint and no appointments or medical cards are needed. Walk-ins are welcome! Must be 21+ with a valid ID. All The Buzz Reviews Recent Reviews Infused Truffles - Georgetown Kushcakes As cannabis reviewers I'm sure you all can imagine that we end up meeting an extremely diverse array of businesses and business types on... Toker's Guide Aug 27, 2021 3 min read Toker Vision - Pre-Roll Edition Since the pandemic started (isn't it over yet?) the cannabis world in DC has evolved considerably. Before the pandemic about 70% of the... Toker's Guide Jul 23, 2021 4 min read Bleu Cheese - All The Buzz Happy Friday Tokers! It's May C. and I'm back to bring you another sparkling review for one of our new favorite storefronts that have... May Jun 11, 2021 2 min read

Hefestus, an Israeli-based, third-generation engineering company, provides automation solutions for the global cannabis market. They are introducing two new proprietary technologies: a patented "donut" infusion method that creates an airflow channel in pre-rolls for a smoother, consistent draw and higher infusion levels, and a Modified Atmosphere Packaging (MAP) system that replaces ambient air with inert gases to prevent mold, preserve terpenes, and maintain potency and freshness in packaged pre-rolls. < Back Automation for a New Era of Cannabis Pre-Roll Manufacturing Nov 21, 2025 Staff MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The phrase “family business” often brings to mind heritage, legacy, and stability, and Hefestus embodies all three. Based in Israel and serving the global cannabis market, the third-generation engineering house is rooted in a tradition of agility and innovation. This fall, the company is introducing two proprietary technologies poised to reshape how infused pre-rolls are made and kept fresh. Patented “donut” infusion for smoother, cleaner draws Infusion has become a major value driver: Consumers want concentrate-level potency with a familiar smoking experience. Brands often saturate biomass with full-spectrum distillate or inject concentrates like rosin or budder into joints, but those methods can cause clogging, uneven burn, or poor draw. Kief-coating, or “stardusting,” is typically manual and inconsistent. Hefestus’s answer is a patented inside-out “donut” infusion method. Instead of pushing concentrate into the center of a pre-roll, the joint is engineered with a tiny airflow channel through the core. The result is consistent burn and a smoother draw without clogging, canoeing, or sacrificing smokability at higher infusion levels. The new donut-making equipment provides a fully automated, scalable solution compatible with multiple formats including pre-rolls, blunts, and cones. Simple in concept but bold in execution, the system reflects Hefestus’s core strength: bridging high-precision engineering with cannabis manufacturing challenges. [image: The Hefestus Aura automation unit illuminated against a stylized background showcasing advanced engineering design.] MAP technology that preserves freshness and potency Even when production is dialed in, distribution presents its own obstacles. Flower and pre-rolls are highly sensitive to oxidation, humidity, and terpene loss. In food and pharmaceutical packaging, modified atmosphere packaging (MAP) is widely used to mitigate those issues but cannabis has been slow to adopt it. Hefestus’s MAP system flushes ambient air from packaging like tubes, jars, and multipacks and replaces it with inert gases like nitrogen, dramatically reducing oxygen and humidity. The benefits: mold prevention, terpene preservation, and maintained potency. In short, what ships out is what consumers experience after purchase. “Once flower is ground and rolled, protective packaging becomes even more critical,” said Hefestus USA Chief Executive Officer Shahar Yamay. “Proper MAP sealing helps ensure the pre-roll a customer lights is as fresh as the one that left the production line.” The process is both elegant and robust: After a pre-roll is inserted into its package, the system flushes, seals, and safeguards the internal atmosphere while still allowing for labeling and visibility. It transforms packaging from a container into a quality-preservation system. [image: A technician loading materials into a Hefestus automated pre-roll system inside a production facility.] Automation that scales with modern cannabis operations In cannabis manufacturing, automation is no longer optional. Brands relying on manual labor for filling, infusion, and sealing face higher costs, inconsistent quality, and limited scalability. With decades of automation experience across food, pharma, and consumer goods, Hefestus brings proven precision to cannabis operations. “We stay ahead of the game, we listen to our customers, and we adjust in real time,” said Head of Business Development Tomer Oliel. “Our goal is to strengthen our customers’ success through innovation that’s practical and reliable.” With technical rigor and real-world usability, Hefestus helps producers deliver consistency, smoother experiences, and longer shelf life—engineering progress without losing sight of its roots. *hefestus-tech.com* [image: The Hefestus engineering and production team standing together inside their workshop.]The multi-generational engineering family behind Hefestus. (Photo: Hefestus) ------------------------------ The science behind better pre-rolls 1. What is Hefestus’s donut infusion technology? Hefestus uses a patented airflow channel at the center of the pre-roll, enabling higher infusion levels without clogging, canoeing, or uneven burn. 2. How does MAP sealing keep pre-rolls fresh? The system replaces oxygen with inert gases to reduce humidity, mold risk, and terpene loss—maintaining the product’s intended experience. 3. Why should pre-roll manufacturers automate? Automation reduces labor costs, ensures high-volume consistency, and supports regulatory-grade repeatability that hand-filled processes can’t match. 4. For what industries has Hefestus engineered? The company brings decades of automation expertise from food, pharma, and consumer goods—now adapted for cannabis production. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A St. Louis jury awarded cannabis consultant Mark Avent $2.5 million and his wife, Lisa, $500,000 in damages—totaling $3 million—stemming from a 2022 accident at Blue Arrow Missouri LLC where mishandled equipment caused cannabis particles to trigger a severe asthma attack and heart attack, effectively ending his career. The jury found Blue Arrow 85% at fault for the incident, which resulted in Avent losing at least $130,000 annually in income. < Back Jury Awards Cannabis Consultant $3M in Damages Related to Accident at St. Louis Facility Nov 25, 2025 TG Branfalt Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A St. Louis, Missouri jury last week awarded a cannabis consultant $3 million in damages stemming from a 2022 accident at a cannabis laboratory that ended his career in the industry, the Missouri Independent reports. Mark Avent was helping build out the Blue Arrow Missouri LLC in St. Louis when a lab technician accidentally mishandled a commercial vacuum used to clean equipment. The vacuum blew fine cannabis particles into the air, and Avent suffered a severe asthma attack that led to a heart attack. Following a four-day trial, the jury unanimously found that Blue Arrow was at fault for 85% of Avent’s injuries, while Avent was 15% at fault, and awarded $2.5 million in damages to Avent and $500,000 to his wife, Lisa, for distress. Avent had sought $5 million in damages. A separate lawsuit will determine which of Blue Arrow’s insurance companies will cover the award, but John Wilbers, founder and chairman of Blue Arrow – and a personal injury attorney himself – told the Independent that “If somebody’s injured, we’re going to help them.” Avent said that on top of the medical bills, which included ambulance service and a stent in his heart, he has lost at least $130,000 a year because he can no longer work in the industry. Blue Arrow’s attorneys did not indicate whether they plan to appeal the verdict. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Miel Wellness WEBSITE MENU REVIEWS 727 8th Street Southeast, Washington, DC, USA About OVERALL 2.9 average rating is 2.9 out of 5 EXPERIENCE 3.1 average rating is 3.1 out of 5 QUALITY 3.0 average rating is 3 out of 5 SERVICE 2.9 average rating is 2.9 out of 5 SELECTION 3.0 average rating is 3 out of 5 PRICES 2.8 average rating is 2.8 out of 5 Miel Wellness on 8th Street SE offers a honeyed retreat for cannabis users. The dispensary features sweet strains and infused products in a smooth, inviting space. It’s perfect for those seeking a gentle cannabis experience. The staff drizzles customers with attentive care. A sweet escape for cannabis lovers. Recent Reviews Check back soon Once posts are published, you’ll see them here. Trending Nearby Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... Platinum TK - Green Theory Dispensary Platinum TK is an indica-dominant hybrid from the skilled cultivators at Alt Sol that offers a robust and relaxing experience. Currently... Gelato Cake by District Cannabis - Monko DC Gelato Cake has come to be, for all intents and purposes, the flagship strain of local cultivator District Cannabis. It's an indica-domin... 1 2 3 4 5 best weed in DC (1,159) 1,159 posts DC flower (1,084) 1,084 posts DC I-71 (1,029) 1,029 posts terps (996) 996 posts DC Storefront (670) 670 posts heavy trichomes (660) 660 posts Indica Heavy Hybrid (611) 611 posts DC weed delivery (534) 534 posts starry trichomes (509) 509 posts Indica (475) 475 posts 50/50 Hybrid (421) 421 posts Sativa Dominant Hybrid (252) 252 posts Sativa (211) 211 posts Gelato (154) 154 posts DC Medical Marijuana (146) 146 posts Medical Marijuana (138) 138 posts Maryland Medical Marijuana (112) 112 posts Maryland Flower (104) 104 posts Runtz (101) 101 posts Elevated Lounge (95) 95 posts GSC (91) 91 posts alternative solutions (84) 84 posts Takoma Wellness Center (80) 80 posts The Gift Givers (78) 78 posts Maryland Recreational (75) 75 posts concentrate (74) 74 posts best weed in Maryland (74) 74 posts edibles (69) 69 posts Zkittles (69) 69 posts Alt Sol (59) 59 posts

A powerful GOP-led congressional committee amended a report for a spending bill containing provisions that hemp stakeholders say would upend the industry, clarifying that the panel does not intend to prohibit non-intoxicating cannabinoid products with “trace or insignificant amounts of THC” that were federally legalized during the first Trump administration... < Back Congressional Committee Clarifies That Hemp Ban Isn’t Meant To Restrict ‘Industrial Or Nonintoxicating’ Products Jun 13, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A powerful GOP-led congressional committee amended a report for a spending bill containing provisions that hemp stakeholders say would upend the industry, clarifying that the panel does not intend to prohibit non-intoxicating cannabinoid products with “trace or insignificant amounts of THC” that were federally legalized during the first Trump administration. About a week after clearing a subcommittee, the legislation was taken up in the House Appropriations Committee on Wednesday, where members adopted a manager’s amendment that provides the clarifying language—albeit in the report attached to the bill, rather than in the legislative text itself. The 138-page measure covers a wide range of issues, but for the hemp industry, there’s a section of particular concern that would redefine hemp under federal statute in a way that would prohibit cannabis products containing any “quantifiable” amount of THC or “any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals” as THC. Rep. Andy Harris (R-MD)—chair of the House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies—said in opening remarks at the hearing that the legislation “closes the loop hemphole,” before correcting himself to say “the hemp loophole from the 2018 Farm Bill.” He argued that the policy “has resulted in the proliferation of intoxicating cannabinoid products, including delta-8 and hemp flower, being sold online and in gas stations nationwide under the false guise of being ‘USDA approved.'” As many states have stepped in to curb these dangerous project products from reaching consumers, particularly children, it’s time for Congress to act to close this loophole while protecting industrial hemp industry,” Harris said. “Reports that the included language would destroy legitimate businesses are simply not true, and that’s clear to anyone closely reading the carefully drafted language that I believe threaded the needle.” Despite Harris’s strong opposition to cannabis reform and criticism of intoxicating hemp products, his manager’s amendment to the report notably expresses the intent of the committee to take a more flexible regulatory approach to certain cannabis items. “In determining the quantifiable amounts, the Committee does not intend for industrial or nonintoxicating hemp-derived cannabinoid products with trace or insignificant amounts of THC to be affected,” it says. Update: the attached file replaces the previously-posted file for the Ag/FDA – Harris (MD) #1 – Manager’s Amendment https://t.co/tQX4KGf1Ir pic.twitter.com/IGhTZaUZ7o — House Appropriations Amendments (@AppropsAmendmts) June 12, 2025 But the language in the bill itself would still effectively eliminate the most commonly marketed hemp products within the industry, as even non-intoxicating CBD items that are sold across the country typically contain trace amounts of THC. Under current law, those products are allowed if they contain no more than 0.3 percent THC by dry weight. The proposed policy championed by Harris would drastically change that. It would instead maintain the legal status of “industrial hemp” under a revised definition that allows for the cultivation and sale of hemp grown for fiber, whole grain, oil, cake, nut, hull, microgreens or “other edible hemp leaf products intended for human consumption.” While there were expectations that the committee would vote on the bill this week, members ultimately did not finish their work on the legislation. And with the House on recess next week, it’s not yet clear when they will do so. The hemp language is largely consistent with appropriations and agriculture legislation that was introduced, but not ultimately enacted, under the last Congress. Rep. Dan Newhouse (R-WA) said at Wednesday’s hearing that he and Harris “have worked very hard to protect the industrial hemp industry while closing loopholes that were created in the 2018 Farm Bill.” “So, I want to thank everybody for the efforts working on that issue,” he said. “I think that we’ve come to a very reasonable outcome.” Hemp industry stakeholders rallied against that proposal, an earlier version of which was also included in the base bill from the subcommittee last year. It’s virtually identical to a provision of the 2024 Farm Bill that was attached by a separate committee last May via an amendment from Rep. Mary Miller (R-IL), which was also not enacted into law. There are some differences between the prior spending bill and this latest version for 2026, including a redefining of what constitutes a “quantifiable” amount of THC that’d be prohibited for hemp products. It now says that a quantifiable amount is “based on substance, form, manufacture, or article (as determined by the Secretary of Health and Human Services in consultation with the Secretary of Agriculture),” whereas it was previously defined as an amount simply “determined by the Secretary in consultation with the Secretary of Health and Human Services.” The proposed legislation also now specifies that the term hemp does not include “a drug that is the subject of an application approved under subsection (c) or (j) of section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355),” which seems to carve out an exception for Food and Drug Administration- (FDA) approved drugs such Epidiolex, which is synthesized from CBD. A leading alcohol industry association, meanwhile, has called on Congress to dial back language in the House spending bill that would ban most consumable hemp products, instead proposing to maintain the legalization of naturally derived cannabinoids from the crop and only prohibit synthetic items. Wine & Spirits Wholesalers of America (WSWA) President and CEO Francis Creighton said in a press release on Thursday that “proponents and opponents alike have agreed that this language amounts to a ban.” “By pushing a rapidly evolving industry back into the shadows, Congress is creating even more chaos in the marketplace, undermining state initiatives and punishing responsible actors,” he said. “We urge the full House to reconsider this approach. States can regulate intoxicating products safely and effectively through systems that preserve consumer trust and public safety. It’s time for Congress to follow their lead, not override their authority.” Members of Wine & Spirits Wholesalers of America (WSWA) also met with lawmakers and staffers in April to advocate for three key policy priorities that the group says is based on “sound principles of alcohol distribution.” They include banning synthetic THC, setting up a federal system for testing and labeling products and establishing state-level power to regulate retail sales. Separately, key GOP congressional lawmakers—including one member who supports marijuana legalization—don’t seem especially concerned about provisions in a new spending bill that would put much of the hemp industry in jeopardy by banning most consumable products derived from the plant. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Jonathan Miller, general counsel of the U.S. Hemp Roundtable, told congressional lawmakers in April that the market is “begging” for federal regulations around cannabis products. At the hearing, Rep. James Comer (R-KY) also inquired about FDA inaction around regulations, sarcastically asking if it’d require “a gazillion bureaucrats that work from home” to regulate cannabinoids such as CBD. A report from Bloomberg Intelligence (BI) last year called cannabis a “significant threat” to the alcohol industry, citing survey data that suggests more people are using cannabis as a substitute for alcoholic beverages such a beer and wine. Last November, meanwhile, a beer industry trade group put out a statement of guiding principles to address what it called “the proliferation of largely unregulated intoxicating hemp and cannabis products,” warning of risks to consumers and communities resulting from THC consumption. Feds Warn Retailers That Accepting Welfare Benefits For Marijuana Or CBD Could Result In ‘Criminal Prosecution’ *Photo courtesy of Brendan Cleak.* The post Congressional Committee Clarifies That Hemp Ban Isn’t Meant To Restrict ‘Industrial Or Nonintoxicating’ Products appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The Massachusetts House passed a bill to raise cannabis license caps, increase purchase limits, and regulate hemp-derived products. The bill would also change how the Cannabis Control Commission (CCC) members are selected. Concerns have been raised that the changes could favor large operators over smaller businesses. < Back Massachusetts House Passes Bill to Overhaul Cannabis Regulatory Agency, Increase License Caps and Purchase Limits Jun 10, 2025 TG Branfalt Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Massachusetts House last week passed a bill that would raise the caps on the number of retail cannabis licenses an individual or entity can hold, increase daily purchase limits from 1 ounce of flower to 2 ounces, and regulate intoxicating beverages and consumable derived from hemp, WGBH reports. The bill would also overhaul how members of the state Cannabis Control Commission (CCC) are selected, taking the governor alone with appointing a full-time chair and two part time associate commissioners. Under current law, passed in 2017, the CCC is comprised of five members who members are appointed by the treasurer, attorney general, and governor, with the treasurer selecting the chair. In an interview with WGBH, state Rep. Daniel Donahue (D), House chair of the Cannabis Policy Committee, said the changes “still protect the commissioners’ independence in policymaking and in investigations and adjudications of violations.” “The cannabis industry, with its complexities and challenges, requires a nimble and efficient regulator.” — Donahue to WGBH The proposal comes about a year after state Inspector General Jeffrey Shapiro asked lawmakers to take charge of a “rudderless agency.” During a hearing with lawmakers last July, Shapiro described the CCC as a “train wreck” and the “Wild West” and suggested lawmakers appoint a receiver to oversee the agency. In 2023, state Treasurer Deborah Goldberg suspended then-chair Shannon O’Brien and ultimately removed her from the role. O’Brien is currently challenging the firing in court. In a statement, Shanel Lindsay, co-founder of advocacy group Equitable Opportunities Now, raised concerns with the proposed CCC changes and argued that raising the cap on licenses could make way for large, multi-state operators to move in at the expense of small, local businesses, describing the move as “a gift to corporate cannabis and a death sentence for local and social equity businesses.” How is someone with one, two, or three stores supposed to compete with someone buying for six or more stores?” Lindsay said in the statement. “It will undermine everything Massachusetts has worked so hard to achieve in building the most equitable cannabis industry in the country.” The bill moves next to the state Senate. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

*LOS ANGELES —* On Father’s Day, Snoop Dogg and Death Row Records Cannabis launched TryDeathRow.com, a nationwide e-commerce platform that brings West Coast hip-hop and cannabis culture to consumers nationwide. The website features hemp-derived products, including CBD and Delta-9 THC items personally vetted by Dogg. TryDeathRow.com is the hemp lifestyle extension of Death Row Records, offering hemp-derived products and merchandise inspired by the fusion of music and cannabis culture. < Back Snoop Dogg Launches New E-Commerce Venture for Death Row Cannabis Jun 17, 2025 Mg Magazine Newswire MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *LOS ANGELES —* On Father’s Day, Snoop Dogg and Death Row Records Cannabis launched TryDeathRow.com, a nationwide direct-to-consumer e-commerce platform that brings the unapologetic spirit of West Coast hip-hop and cannabis culture to consumers nationwide. The hemp-derived THC lifestyle site marks the next evolution of Death Row Records under Snoop’s leadership and further expands his empire. The launch follows Dogg’s 2022 acquisition of the legendary Death Row Records — the iconic label that defined a generation with artists like Dr. Dre, Tupac, and Dogg himself. Shortly after taking the reins, Dogg launched Death Row Records Cannabis, curating a premium catalog designed for both seasoned connoisseurs and the everydayers. With the debut of TryDeathRow.com, Dogg is expanding that vision nationwide, giving everyone access to the hemp-derived products he stands behind. “The magic of Death Row Records has always been about realness — music that spoke to the people who lived it,” said Dogg. “TryDeathRow.com builds on the brand’s authenticity, culture, and connection. This is the place cannabis was meant to live.” The website features a selection of federally compliant hemp-derived products, including CBD and Delta-9 THC items personally vetted by Dogg. Only buds make the cut — no seeds, no stems, no sticks — just top-shelf flower. The site will also offer beverages, edibles, and other Death Row offerings. The site allows consumers to explore the full collection and experience the next chapter of Death Row’s legacy — where music, cannabis, and culture collide. About TryDeathRow.com TryDeathRow.com is the hemp lifestyle extension of Death Row Records, offering a curated selection of hemp-derived products and additional merchandise inspired by the fusion of music and cannabis culture. Founded by Snoop Dogg, TryDeathRow.com delivers a premium, direct-to-consumer experience grounded in authenticity, legacy, and innovation. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Jason Gellman of Ridgeline Farms believes that selling genetics to companies that can expand his reach is the most effective strategy to overcome the oversupply in California's legal market. < Back Lifelong Humboldt County Cultivator Goes Global to Fight Cratering Prices Oct 17, 2025 Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Jason Gellman of Ridgeline Farms says selling genetics to companies that can amplify his reach is the best way to survive oversupply in California’s legal market. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A top conservative organization, the Koch-founded Americans for Prosperity Foundation (AFPF), is backing a coalition of marijuana businesses urging the U.S. Supreme Court to hear a case challenging federal cannabis prohibition. AFPF argues that the Controlled Substances Act (CSA), as applied to intrastate marijuana activity in legal states like Massachusetts, exceeds constitutional limits on federal authority and violates the Commerce Clause and principles of federalism. < Back Top Conservative Group Urges Supreme Court To Take Marijuana Case Challenging Federal Prohibition Nov 20, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A top conservative advocacy organization is backing a coalition of marijuana businesses that are asking the U.S. Supreme Court to take up a case challenging the constitutionality of federal cannabis prohibition. In an amicus brief filed with the court on Wednesday, the Koch-founded Americans for Prosperity Foundation (AFPF) implored justices to hear the case and settle the question of whether imposing federal marijuana criminalization within states that have enacted their own legalization laws violates the Commerce Clause of the U.S. Constitution. The libertarian-leaning AFPF said in the brief that it’s their organization’s belief that “the general power of governing rests with the States—not the federal government—and that most decisions should be made at the state and local levels, reflecting the needs and priorities of their communities.” To that end, it said, the Controlled Substances Act (CSA) that treats cannabis as a strictly prohibited Schedule I drug—at least as it concerns the Massachusetts-based marijuana businesses petitioning the court—”exceeds constitutional limits on federal authority as an original matter and cannot be squared with basic principles of federalism.” “More broadly, AFPF believes that *Gonzales v. Raich*—a constitutional aberration granting the federal government authority to trample on States’ core power to choose whether and how to regulate local private conduct—was wrongly decided and should be squarely overruled,” it said. In* Gonzales v. Raich*, a landmark 2005 case, the Supreme Court narrowly determined that the federal government could enforce prohibition against cannabis cultivation that took place wholly within California based on Congress’s authority to regulate interstate commerce. The new case “is not about sound public policy or the wisdom of Massachusetts’ regulatory choices. The core question here is whether the federal government may trespass on and override exercises of States’ traditional police power to regulate purely local activity and decide for themselves how best to protect the health, safety, and welfare of their residents,” AFPF said. “Under our system of federalism, the answer is no.” “As applied to Petitioners—which ‘cultivate, manufacture, possess, and/or distribute marijuana wholly within Massachusetts in full compliance with its laws and regulations,’—the CSA is an affront to our system of federalism. It federally criminalizes wholly intrastate activity not intended for and without any empirically demonstrable link to interstate commerce. This assertion of general police power is unconstitutional.” AFPF—supporting the petitioners Canna Provisions, Gyasi Sellers, Wiseacre Farm and Verano Holdings—said justices should “sweep *Raich* into the dustbin and squarely overrule it.” “The Petition presents an ideal (and rare) opportunity to begin to ‘temper’ and ‘modify,’ this Court’s Commerce Clause and Necessary and Proper Clause jurisprudence to bring it closer in line with the Constitution’s original public meaning. This Court should take up that task. This Court should end *Raich’s* ‘rational basis’ error by squarely overruling that aberration and making clear that the Constitution requires more before the federal government may intrude on the core police powers it reserves to the States. As Petitioners explain, the sky will not fall if this Court takes that modest step. On the contrary, our constitutional republic will be healthier for it.” The powerhouse law firm Boies Schiller Flexner LLP last month submitted their petition for writ of certiorari from the court on behalf of their clients, and the Justice Department last week declined the opportunity to file a brief for or against the case’s consideration by the justices. A lead attorney representing the petitioners recently told Marijuana Moment that he’s “hopeful”—albeit somewhat “nervous”—about the prospect of justices ultimately taking up the matter and deciding to address the key legal question about the constitutionality of federal cannabis prohibition. “Time is of the essence,” Josh Schiller said, noting the dramatic shift in public opinion and state laws governing cannabis. “We think that this is the right time for this case because of the need—the industry needs to get relief from federal oversight at the moment.” A U.S. appeals court rejected the arguments of the state-legal cannabis companies the firm is representing in May. It was one the latest blows to the high-profile lawsuit following a lower court’s dismissal of the claims. But it’s widely understood that the plaintiffs’ legal team has long intended the matter to end up before the nine high court justices. Four justices must vote to accept the petition for cert in order for the court to take up the case. The next step would have been for the Department of Justice to file its initial brief, which had a due date of November 28. It remains to be seen if the court will end up requesting a brief from the government now that it has declined to do so on its own accord. While it is not clear if SCOTUS will ultimately take the case, one sign that at least some on court might be interested in the appeal is a 2021 statement from Justice Clarence Thomas, issued as the court denied review of a separate dispute involving a Colorado medical marijuana dispensary. Thomas’s comments at the time seemed to suggest it’d be appropriate revisit *Raich*—a move that could upend federal prohibition. The statement pointed to policy developments since the earlier case was decided, such as the hands-off enforcement approach taken by the Department of Justice as more states legalized cannabis and a congressional budget rider protecting state-legal medical marijuana programs. “Whatever the merits of *Raich* when it was decided, federal policies of the past 16 years have greatly undermined its reasoning,” Thomas wrote, describing the government’s approach to cannabis enforcement as “a half-in, half-out regime that simultaneously tolerates and forbids local use of marijuana.” “Though federal law still flatly forbids the intrastate possession, cultivation, or distribution of marijuana…the Government, post-*Raich*, has sent mixed signals on its views,” the justice continued, saying the situation “strains basic principles of federalism and conceals traps for the unwary.” The initial complaint in the current case now known as *Canna Provisions v. Bondi*, filed in U.S. District Court for the District of Massachusetts, argued that government’s ongoing prohibition on marijuana under the CSA was unconstitutional because Congress in recent decades had “dropped any assumption that federal control of state-regulated marijuana is necessary.” *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* At oral arguments on appeal late last year, David Boies told judges that under the Constitution, Congress can only regulate commercial activity within a state—in this case, around marijuana—if the failure to regulate that in-state activity “would substantially interfere [with] or undermine legitimate congressional regulation of *inter*state commerce.” Boies, chairman of the firm, has a long list of prior clients that includes the Justice Department, former Vice President Al Gore and the plaintiffs in a case that led to the invalidation of California’s ban on same-sex marriage, among others. Judges, however, said they were “unpersuaded,” ruling in an opinion that “the CSA remains fully intact as to the regulation of the commercial activity involving marijuana for non-medical purposes, which is the activity in which the appellants, by their own account, are engaged.” The district court, meanwhile, said in the case that while there are “persuasive reasons for a reexamination” of the current scheduling of cannabis, its hands were effectively tied by past U.S. Supreme Court precedent in *Raich*. This comes in the background of a pending marijuana rescheduling decision from the Trump administration. President Donald Trump said in late August that he’d make a determination about moving cannabis to Schedule III of the CSA within weeks, but he’s yet to act. Meanwhile, last month the Supreme Court agreed to hear a separate case on the constitutionality of a federal law prohibiting people who use marijuana or other drugs from buying or possessing firearms. The Trump administration has argued that the policy “targets a category of persons who pose a clear danger of misusing firearm” and should be upheld. The post Top Conservative Group Urges Supreme Court To Take Marijuana Case Challenging Federal Prohibition appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A Seattle-based craft beverage company sold its cannabis segment, including its Mary Jones brand assets, to MJ Reg Disrupters. < Back Jones Soda Co. Divests Cannabis Beverage Business for $3 Million Jun 23, 2025 Staff Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Seattle-based craft beverage company sold its cannabis segment to MJ Reg Disrupters, including its Mary Jones brand assets. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The editorial team identified five major takeaways from MJBizCon 2025, noting that the power of marijuana flower is essential to industry success. < Back Marijuana flower power at the heart of industry success – and other MJBizCon takeaways Dec 8, 2025 Chris Roberts MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Here are five major takeaways from MJBizCon 2025 as heard by our editorial team. Marijuana flower power at the heart of industry success – and other MJBizCon takeaways is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Bloom Brand, a U.S. leader in cannabis vape, is expanding internationally with a launch in the UK in Q1 2026 through a partnership with New Garden Pharma. This marks Bloom's first international market expansion, with plans for further EU market development in 2026 and beyond. The partnership will provide UK patients access to Bloom's vape collections. New Garden Pharma will lead the UK entry, ensuring a compliant and scalable launch. < Back Bloom to Expand into Europe with New Garden Pharma Partnership Jun 24, 2025 Staff MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *LONDON —* The Bloom Brand, a U.S. leader in cannabis vape, plans to make its international debut in the United Kingdom through an exclusive partnership with New Garden Pharma, a leading European EU-GMP cannabis operator. Together, the two companies will launch Bloom’s award-winning Classic and Live vape collections in the UK in Q1 2026. This marks Bloom’s first international market expansion, as the company continues its global growth strategy with additional EU markets in development for 2026 and beyond. UK patients will gain access to Bloom’s superior formulations and proprietary hardware systems. For more than a decade, Bloom has built its reputation on delivering terpene-rich, flavor-forward strains paired with reliable technology. The brand has an established and leading presence across leading U.S. markets including California, Illinois, Florida, Michigan, Missouri, New Jersey, New Mexico, New York, and Virginia. “Expanding into the UK is a pivotal step towards our mission to reshape the global cannabis experience,” said Ovidiu (David) Chiorpec, Director of Business Development at Bloom. “We’ve spent over a decade building a brand that patients trust in the U.S., and we’re excited to introduce the UK consumer to a new level of excellence and sophistication in the vape category.” New Garden Pharma, medical subsidiary of New Garden Group, is a trusted name in European cannabis manufacturing who combines a unique supply chain model with a proven track record in regulatory compliance and market expansion. With established infrastructure across the continent, the company will lead Bloom’s UK entry — ensuring a compliant, efficient, and scalable launch across all channels. “We’re excited to welcome Bloom to the UK market,” said Alexey Brylev, CEO of New Garden Group. “As an established operator across European medical cannabis markets, we bring the EU-GMP manufacturing expertise, local insight, and regulatory know-how needed to help global brands thrive. This partnership reflects our broader mission: to deliver world-class products to European patients and to raise the bar for quality, safety, and innovation across the continent.” < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5